Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Paola Matteucci"'
Autor:
Filippo de Braud, Francesca De Santis, Roberta Zappasodi, Massimo Di Nicola, Margherita Ambrosini, Michele Magni, Luca Agnelli, Silvia Brich, Francesco Sgambelluri, Roberta Mortarini, Serenella M Pupa, Liliana Devizzi, Paola Matteucci, Antonello Cabras, Andrea Anichini, Alessandro M Gianni
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
We previously published the results of a pilot study showing that vaccination with tumor-loaded dendritic cells (DCs) induced both T and B cell response and produced clinical benefit in the absence of toxicity in patients with relapsed, indolent non-
Externí odkaz:
https://doaj.org/article/f9ca43637fe4422fb209fd32c96031a5
Autor:
Giuseppe Colloca, Mauro Guglielmo, Rosa Liperoti, Marianna Luciana Ferrara, Liliana Devizzi, Paola Matteucci, Stephan Hohaus, Beatrice Di Capua, Lucia Farina, Carla Ripamonti, Patricia Di Pede, Domenico Fusco, Roberto Bernabei, Domenico La Carpia
Publikováno v:
Journal of Geriatric Oncology. 11:790-795
Objectives To compare cognition in a group of older long-term survivors from Non-Hodgkin Lymphoma (NHL) and in a corresponding group of non-cancer controls of the same age. Functional status, polypharmacy and multimorbidity were also evaluated. Metho
Autor:
C. Carniti, Francesco Barretta, Angela Passi, Alessandro Re, Giorgio Rossi, Anna Dodero, Paolo Corradini, Paola Matteucci, Giancarlo Pruneri, M. C. Di Chio, M. Novo, Anna Guidetti, L. Devizzi, Alessandra Tucci, Alessio Pellegrinelli, Adele Testi, Rosalba Miceli, Fabio Facchetti, Martina Pennisi
Publikováno v:
Leukemia
Autor:
Alessandro Massimo Gianni, Giovanni Fucà, Roberta Mortarini, Roberta Zappasodi, Francesca De Santis, Luca Agnelli, Michele Magni, Margherita Ambrosini, Liliana Devizzi, Francesco Sgambelluri, Andrea Anichini, Filippo de Braud, Silvia Brich, Massimo Di Nicola, Paola Matteucci, Antonello Cabras, Serenella M. Pupa
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
We previously published the results of a pilot study showing that vaccination with tumor-loaded dendritic cells (DCs) induced both T and B cell response and produced clinical benefit in the absence of toxicity in patients with relapsed, indolent non-
Autor:
Attilio Olivieri, Corrado Tarella, Roberto Passera, Guido Gini, Daniele Caracciolo, Massimo Di Nicola, Michele Magni, Paola Matteucci, Riccardo Bruna, Andrea Riccardo Filippi, Paolo Corradini, Liliana Devizzi, Marco Ladetto, Guido Parvis, Marco Ruella, Umberto Ricardi, Anna Di Russo
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 94:783-791
Rituximab (Rit) therapy added to involved-field radiation therapy (RT) has been proposed as an effective treatment for stage I-II follicular lymphoma (FL). The results of an observational multicenter study on the Rit-RT combination in limited-stage F
Autor:
P. Valagussa, V. Bonfante, Liliana Devizzi, Carmelo Carlo-Stella, Antonio Di Stasi, Alessandro M. Gianni, Simonetta Viviani, Massimo Di Nicola, Paola Matteucci, Michele Magni
Publikováno v:
Leukemia & Lymphoma. 51:1251-1259
The introduction of high-dose (HD) chemotherapy (CT) and autologous stem cell (ASCT) or bone marrow transplant (ABMT) in the last two decades has improved the prognosis of patients with refractory or relapsed Hodgkin lymphoma (HL) over conventional-d
Autor:
Antonino Carbone, Irene Ricca, Cristiana Carniti, Anna Guidetti, Michele Magni, Adele Testi, Liliana Devizzi, Massimo Di Nicola, Antonello Cabras, Paola Matteucci, Alessandro M. Gianni, Carmelo Carlo-Stella, Valeria Bonfante, Simonetta Viviani
Publikováno v:
Leukemia Research. 34:e1-e4
This study describes a patient with a relapsed, diffuse, large B cell lymphoma (DLBCL) treated with radioimmunotherapy (RIT) with yttrium-90 ((90)Y)-ibritumomab tiuxetan (Zevalin) who 5 months later developed acute myeloid leukemia (AML) with inversi
Autor:
Nicola Nicolai, Carmelo Carlo-Stella, Carmelo Bengala, Silvia Stagni, Elena Farè, Salvatore Siena, Paola Matteucci, Luigi Piva, M. Di Nicola, Tullio Torelli, Carlo Barone, Roberto Salvioni, A.M. Gianni, Patrizia Giannatempo, Davide Biasoni, S. Lo Vullo, Luigi Mariani, Ilaria Schiavetto, Michele Magni, Andrea Necchi, Mario Catanzaro, Giorgio Pizzocaro, Daniele Raggi
Publikováno v:
Scopus-Elsevier
Background In the late 1990s, the use of high-dose chemotherapy (HDCT) and stem-cell rescue held promise for patients with advanced and poor prognosis germ-cell tumors (GCT). We started a randomized phase II trial to assess the efficacy of sequential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f744cd058ed3579bd9cae493fc92b1eb
Autor:
Massimo Di Nicola, Paola Matteucci, Roberto Passera, Emilio Bombardieri, Alessandro M. Gianni, Michele Magni, Anna Guidetti, Carmelo Carlo-Stella, Corrado Tarella, Ettore Seregni, Adele Testi, Liliana Devizzi, Marco Ruella, Simonetta Viviani, Carlo Chiesa, Marco Maccauro, Maria Cristina Cox
Publikováno v:
Journal of Clinical Oncology. 31:2974-2976
NOTE. Median follow-up, 5.7 years (range, 1-8.7); Z-HDS, 5.9 (range, 1-8.3); HDS, 4.9 (range, 1.4-8.7).
Autor:
Maura Massimino, Anna Guidetti, Lorenza Gandola, Carmelo Carlo-Stella, Liliana Devizzi, Jacopo Mariotti, Antonello Cabras, Massimo Di Nicola, Paola Matteucci, Alessandro M. Gianni, Michele Magni
Publikováno v:
British Journal of Haematology. 126:815-820
Summary A very short, intensive paediatric chemotherapy programme was tested in a consecutive monoinstitutional group of 22 adult Burkitt’s lymphoma (BL) patients. After a 5-week induction phase of weekly infusions consisting of vincristine, cyclop